Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Australia
COVID-19
English (EN)
2022
Clear all
Type of publications
NITAG documentation
(10)
Topics
Regions
Western Pacific
(10)
Countries
Australia
(10)
Belgium
(4)
Canada
(13)
France
(1)
Ireland
(4)
Netherlands
(1)
Uganda
(3)
United Kingdom
(4)
United States of America
(11)
Diseases
COVID-19
(10)
Japanese encephalitis
(1)
Mpox // Monkeypox
(1)
Publication date
2022
(10)
2023
(5)
2021
(11)
2020
(2)
Target population
Children
(1)
Available to download in languages
English (EN)
(10)
10 results found
2022
∙
ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
2022
∙
ATAGI
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
2022
∙
ATAGI
COVID-19 vaccination – Guidance on myocarditis and pericarditis after COVID-19 vaccines
2022
∙
ATAGI
Novavax vaccine for adolescents aged 12-17 years
2022
∙
ATAGI
ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years
2022
∙
ATAGI
ATAGI recommendations on the use of a booster dose of COVID-19 vaccine
2022
∙
ATAGI
ATAGI statement on defining 'up-to-date' status for COVID-19 vaccination
2022
∙
ATAGI
ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine
2022
∙
ATAGI
ATAGI updated recommendations for a winter dose of COVID-19 vaccine
2022
∙
ATAGI
Expanded ATAGI recommendations on winter COVID-19 booster doses for people at increased risk of severe COVID-19
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register